Literature DB >> 8537686

Factors associated with cytomegalovirus infection among human immunodeficiency virus type 1-seronegative and -seropositive women from an urban minority community.

L M Clarke1, A Duerr, J Feldman, M F Sierra, B J Daidone, S H Landesman.   

Abstract

Cytomegalovirus (CMV) seroprevalence and genital tract shedding in human immunodeficiency virus (HIV)-seronegative and HIV-seropositive women from an urban minority community were investigated. CMV seropositivity was high in both groups: 181 (95.2%) of 190 HIV-negative and 158 (90.3%) of 175 HIV-positive subjects. Cervicovaginal shedding was detected in 8 (4.4%) CMV-positive HIV-negative subjects and 31 (19.6%) HIV-positive subjects (odds ratio [OR], 5.28; P < .001). Multiple logistic regression analysis revealed that CMV shedding was independently associated with younger age (OR = 0.90; P < .001) and concurrent Chlamydia trachomatis or Neisseria gonorrhoeae infection (OR = 3.60; P = .08). However, shedding was observed over a broad age range in HIV-positive subjects, with 54.8% of shedders being > or = 30 years old. Among HIV-positive subjects, CMV shedding was also associated with decreased CD4 cell counts (P = .04) and, compared with HIV-negative subjects, was significantly higher (P < .001) among subjects with CD4 cell counts < 500 x 10(6)/L (26.5% in subjects with counts < or = 200 and 22.1% in subjects with counts of 201-499 x 10(6)/L).

Entities:  

Mesh:

Year:  1996        PMID: 8537686     DOI: 10.1093/infdis/173.1.77

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Rhesus cytomegalovirus encodes seventeen microRNAs that are differentially expressed in vitro and in vivo.

Authors:  Meaghan H Hancock; Rebecca S Tirabassi; Jay A Nelson
Journal:  Virology       Date:  2012-02-02       Impact factor: 3.616

2.  Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.

Authors:  D A Wohl; M A Kendall; J Andersen; C Crumpacker; S A Spector; J Feinberg; B Alston-Smith; S Owens; S Chafey; M Marco; S Maxwell; N Lurain; D Jabs; C Benson; P Keiser; M A Jacobson
Journal:  HIV Clin Trials       Date:  2009 May-Jun

Review 3.  Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection.

Authors:  Michael J Cannon; Terri B Hyde; D Scott Schmid
Journal:  Rev Med Virol       Date:  2011-06-15       Impact factor: 6.989

4.  Cytomegalovirus-specific T cell immunity is maintained in immunosenescent rhesus macaques.

Authors:  Luka Cicin-Sain; Andrew W Sylwester; Shoko I Hagen; Don C Siess; Noreen Currier; Alfred W Legasse; Miranda B Fischer; Caroline W Koudelka; Michael K Axthelm; Janko Nikolich-Zugich; Louis J Picker
Journal:  J Immunol       Date:  2011-07-15       Impact factor: 5.422

Review 5.  The "silent" global burden of congenital cytomegalovirus.

Authors:  Sheetal Manicklal; Vincent C Emery; Tiziana Lazzarotto; Suresh B Boppana; Ravindra K Gupta
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

6.  Mother-to-Child Transmission of Cytomegalovirus and Prevention of Congenital Infection.

Authors:  Robert F Pass; Brenna Anderson
Journal:  J Pediatric Infect Dis Soc       Date:  2014-09       Impact factor: 3.164

7.  Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whites.

Authors:  B K Hamilton; L Rybicki; M Sekeres; M Kalaycio; R Hanna; R Sobecks; R Dean; H Duong; B T Hill; B Bolwell; E Copelan
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

8.  Seroprevalence of cytomegalovirus (CMV) and risk factors for infection in adolescent males.

Authors:  Laura Patricia Stadler; David I Bernstein; S Todd Callahan; Jennifer Ferreira; Gina A Gorgone Simone; Kathryn M Edwards; Lawrence R Stanberry; Susan L Rosenthal
Journal:  Clin Infect Dis       Date:  2010-10-11       Impact factor: 9.079

9.  Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue.

Authors:  Andrea M Fox-Canale; Thomas J Hope; Jeffrey Martinson; John R Lurain; Alfred W Rademaker; James W Bremer; Alan Landay; Gregory T Spear; Nell S Lurain
Journal:  Virology       Date:  2007-08-22       Impact factor: 3.616

10.  HIV type 1 and cytomegalovirus coinfection in the female genital tract.

Authors:  Nell S Lurain; Emmanuel S Robert; Jiahong Xu; Margaret Camarca; Alan Landay; Andrea A Kovacs; Patricia S Reichelderfer
Journal:  J Infect Dis       Date:  2004-06-30       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.